Searchable abstracts of presentations at key conferences in endocrinology

ea0032p994 | Thyroid (non-cancer) | ECE2013

Association between the use of computed tomography scans using iodine-based contrast medium and the development of subsequent hyperthyroidism

Holmager Pernille , Thomsen Henrik , Faber Jens

Background and aim: There is an increasing use of computed tomography (CT) scans with an iodine-based contrast medium. Last year, a large University Hospital in Denmark performed 50 000 CT scans where each injection contained between 3500 and 7000 μg free iodine corresponding to 23–45 times normal daily intake. We wished to investigate if patients with newly diagnosed hyperthyroidism had been exposed to an iodine based CT scan within 1 year prior to symptoms of hyper...

ea0032p585 | Female reproduction | ECE2013

Thrombin generation in polycystic ovary syndrome: a marker of thrombosis

Aziz Mubeena , Sidelmann Johannes J , Skouby Sven O , Faber Jens

Background: Polycystic ovary syndrome (PCOS) is clinically associated with increased risk of CVD. Thrombin generation (TG) is a measure of the thrombotic potential. This can be expressed as endogenous thrombin potential (ETP) representing the total amount of generated active thrombin over the time (nmol/l×min). ETP is considered the most predictive parameter of thrombosis and is associated to both venous and arterial thrombotic disease. Setting: PCOS women prospectively r...

ea0016p365 | Growth factors | ECE2008

Association between serum levels of insulin-like growth factor-I and development of congestive heart failure: a prospective study in a normal population

Andreassen Mikkel , Raymond Ilan , Kistorp Caroline , Hildebrandt Per , Faber Jens

Background: The growth hormone system (growth hormone, GH and insulin-like-growth-factor I, IGF-I) might be implicated in congestive heart failure (CHF). In experimental models IGF-I increases cardiac contractility and reduces apoptosis of myocytes exposed to ischemic injury. In clinical studies GH-therapy has been used in CHF. One previous population based investigation showed that low levels of IGF-I was associated with an increased incidence of CHF. The result of this inves...

ea0014p371 | (1) | ECE2007

Increased risk of cardiovascular events in subclinical hyperthyroidism

Schultz Marianne , Kistorp Caroline , Raymond Ilan , Faber Jens

Objective: Untreated overt hyperthyroidism is known to predispose the patient to cardiovascular diseases, while predisposition in subclinical hyperthyroidism has been debated. The1 cut-off point of TSH for initiating treatment in subclinical hyperthyroidism is still undefined.Method: A community-based prospective study including non-hospitalised participants, aged 51 to 91 years, living in Copenhagen, Denmark were examined between September 1998 and Janu...

ea0035p651 | Female reproduction | ECE2014

Copeptin in polycystic ovary syndrome

Frossing Signe , Aziz Mubeena , Skouby Sven O , Kistorp Caroline , Faber Jens

Background: Polycystic ovary syndrome (PCOS) is according to the Rotterdam criteria defined as minimum two of: oligomenoré, hyperandrogenism and polycystic ovary. These criteria do not take into account PCOS’ association with the metabolic syndrome (MES) and ischaemic heart disease (IHD). Recently we grouped PCOS- patients into four phenotypes depending on normal/high BMI and insulin resistance (IR). We demonstrated that PCOS-patients with high BMI and increased IR h...

ea0035oc1.2 | Thyroid clinical | ECE2014

Levothyroxine substitution in subclinical hypothyroidism: Does it have a beneficial effect on all-cause mortality?

Andersen Mette Nygaard , Olsen Anne-Marie Schjerning , Madsen Jesper Clausager , Faber Jens , Torp-Pedersen Christian , H. Gislason Gunnar , Selmer Christian

Background: Subclinical hypothyroidism is associated with a number of cardiovascular risk factors such as hypertension, hypercholesterolemia, and diastolic dysfunction, but only limited data exist on long-term outcome of levothyroxine substitution therapy.Objectives: To examine effects of levothyroxine substitution treatment on mortality in patients with subclinical hypothyroidism.Study design: Historical cohort study.<p class=...

ea0035oc1.3 | Thyroid clinical | ECE2014

Chronic liothyronine (T3) treatment in stable heart failure patients with low T3 syndrome: A randomised, double-blind, cross-over, placebo-controlled intervention study (The LIHFA study)

Holmager Pernille , Schmidt Ulla , Dall Mark Peter , Dominguez Helena , Zerahn Bo , Raymond Ilan , Kistorp Caroline , Nygaard Birte , Faber Jens

Background and aim: Low T3 syndrome is associated with a poor prognosis in patients with chronic heart failure (CHF). It is controversial whether T3 treatment is indicated in CHF. A previous study using intravenous infusion of T3 for 72 h suggested a beneficial effect on cardiac performance.We aimed to evaluate the effect of 13 weeks of T3 treatment in patients with stable CHF on left ventricular ejection fraction (LVEF) compared to placebo.<p class=...

ea0032oc3.6 | Thyroid | ECE2013

Subclinical hyperthyroidism and risk of cardiovascular and all-cause mortality

Selmer Christian , Olesen Jonas , Madsen Jesper , Faber Jens , Hansen Peter , Pedersen Ole , Hansen Morten , Torp-Pedersen Christian , Gislason Gunnar

ESE Young Investigator AwardBackground: It is still discussed if subclinical hyperthyroidism and ‘high-normal’ thyroid function are risk-factors for cardiovascular mortality.Objectives: To examine the risk of cardiovascular and all-cause mortality in relation to subclinical hyperthyroidism.Methods: Patients consulting their general practitioner from 2000 to 2009 in Copenhagen, Denmark, who ...

ea0041oc7.5 | Cardiovascular endocrinology | ECE2016

Hypothyroidism and levothyroxine treatment is associated with increased mortality in heart failure patients

Nygaard Andersen Mette , Schjerning Olsen Anne-Marie , Khalid Usman , Lund Kristensen Soren , Faber Jens , Torp-Pedersen Christian , Gislason Gunnar , Selmer Christian

Introduction: Hypothyroidism has detrimental effects on the cardiovascular system but controversy remains over the benefit of levothyroxine substitution in heart failure (hf). The aim of this register based cohort study was to examine the effects of levothyroxine treatment on all-cause mortality in patients with hf.Methods: The study cohort comprised all Danish citizens aged ≥18 years admitted with hf in 1997–2012 and still alive 30 days after...